ArticleCureus2026
Malignant Phyllodes Tumor of the Breast With Multiple Heterologous Sarcomatous Differentiations and Focal Rhabdoid-Like Features: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant phyllodes tumors are rare fibroepithelial breast neoplasms characterized by malignant stromal proliferation and variable biological behavior. We report an exceptionally rare case of a malignant phyllodes tumor with multiple heterologous sarcomatous differentiations and focal rhabdoid-like features. A 50-year-old woman presented with a rapidly enlarging right breast mass. Imaging demonstrated a large Breast Imaging Reporting and Data System (BI-RADS) 4 lesion infiltrating the adjacent pectoral muscle without definite distant metastases. Core needle biopsy revealed an undifferentiated malignant spindle-cell proliferation with diffuse desmin and smooth muscle actin expression, raising suspicion for primary breast leiomyosarcoma or malignant phyllodes tumor with myoid differentiation. The patient underwent right mastectomy with axillary lymph node dissection. Histopathological examination confirmed a 9.5-cm grade 3 malignant phyllodes tumor with stromal overgrowth, high mitotic activity, heterologous chondrosarcomatous, liposarcomatous, and myoid differentiation, and focal rhabdoid-like features without myogenin expression. Surgical margins and lymph nodes were negative. Adjuvant radiotherapy (50 Gy in 25 fractions) was administered. After 17 months of follow-up, no local recurrence or distant metastasis was observed. This case highlights the diagnostic challenges posed by these rare tumors and emphasizes the importance of extensive histopathological sampling, comprehensive immunohistochemical evaluation, complete surgical excision, and selective use of adjuvant radiotherapy in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.